He is likely referring to the fact that MHRA can approve you to market in the UK, but this does not much more than they already have with Specials. They also need NICE approval for reimbursement.
Fortunately, NICE was eagerly anticipating this product 3.5 years ago. It may take a little while but I think we will be OK in the UK. With Project Orbis, we will start seeing the real revenue roll in from America right away, and UK, Germany, Canada and the rest of the EU will follow in due course as is typical, but possibly faster than is typical.
News 
Market Data 
Discover 
AI
